Ignite Creation Date:
2024-05-06 @ 2:12 AM
Last Modification Date:
2024-10-26 @ 11:15 AM
Study NCT ID:
NCT01994057
Status:
RECRUITING
Last Update Posted:
2023-04-12
First Post:
2013-11-01
Brief Title:
A Retrospective Study of EGFR-TKIsGefitinib Erlotinib and Osimertinib in NSCLC Patients Treatment
Sponsor:
Organization:
Sun Yat-sen University
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITH_DNA
Bio Spec Description:
1 FFPE samples of tissue needle biopsy were used for EGFR mutation detection
2 EDTA-whole blood was centrifuged at 4000rpm10minplasma was separated within four hours for somatic mutation detectionThe remaining samples were used for germline mutation detection All the blood samples were frozen in -80 until analysis
Enrollment Count:
1000
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Case-Only |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 23479 |
Who Masked List: